PL357928A1 - Sposób otrzymywania farmaceutycznie czystej polimorficznej postaci I olanzapiny - Google Patents

Sposób otrzymywania farmaceutycznie czystej polimorficznej postaci I olanzapiny

Info

Publication number: PL357928A1
Authority: PL; Poland
Prior art keywords: olanzapine; polymorphic form; pharmaceutically pure; pure polymorphic; obtaining pharmaceutically
Prior art date: 2002-12-20

Application number

PL02357928A

Other languages

English (en)

Other versions

PL202856B1 (pl

Inventor

Zbigniew Majka

Tomasz Stawiński

Original Assignee

ADAMED Sp.z o.o.

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-12-20

Filing date

2002-12-20

Publication date

2004-06-28

2002-12-20 Application filed by ADAMED Sp.z o.o. filed Critical ADAMED Sp.z o.o.

2002-12-20 Priority to PL357928A priority Critical patent/PL202856B1/pl

2003-12-15 Priority to CNB200380106963XA priority patent/CN100354280C/zh

2003-12-15 Priority to BR0317594-4A priority patent/BR0317594A/pt

2003-12-15 Priority to EP03768031A priority patent/EP1581537B1/en

2003-12-15 Priority to CA002506663A priority patent/CA2506663A1/en

2003-12-15 Priority to PCT/IB2003/005931 priority patent/WO2004056833A1/en

2003-12-15 Priority to AU2003292452A priority patent/AU2003292452A1/en

2003-12-15 Priority to HR20050549A priority patent/HRP20050549A2/hr

2003-12-15 Priority to DE60317712T priority patent/DE60317712D1/de

2003-12-15 Priority to UAA200507207A priority patent/UA82213C2/uk

2003-12-15 Priority to ES03768031T priority patent/ES2294333T3/es

2003-12-15 Priority to MXPA05006711A priority patent/MXPA05006711A/es

2004-06-28 Publication of PL357928A1 publication Critical patent/PL357928A1/pl

2005-07-11 Priority to NO20053368A priority patent/NO20053368L/no

2009-07-31 Publication of PL202856B1 publication Critical patent/PL202856B1/pl

Links

KVWDHTXUZHCGIO-UHFFFAOYSA-N olanzapine Chemical compound C1CN(C)CCN1C1=NC2=CC=CC=C2NC2=C1C=C(C)S2 KVWDHTXUZHCGIO-UHFFFAOYSA-N 0.000 title 1
229960005017 olanzapine Drugs 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

PL357928A 2002-12-20 2002-12-20 Sposób otrzymywania farmaceutycznie czystej polimorficznej postaci I olanzapiny PL202856B1 (pl)

Priority Applications (13)

Application Number	Priority Date	Filing Date	Title
PL357928A PL202856B1 (pl)	2002-12-20	2002-12-20	Sposób otrzymywania farmaceutycznie czystej polimorficznej postaci I olanzapiny
HR20050549A HRP20050549A2 (en)	2002-12-20	2003-12-15	A process for the preparation of a pharmaceutically pure polymorphic form i of olanzapine
DE60317712T DE60317712D1 (de)	2002-12-20	2003-12-15	Prozess zum Entfernen von Verunreinigung S von Olanzapin polymorpher Form I
EP03768031A EP1581537B1 (en)	2002-12-20	2003-12-15	Process for removing impurity S from olanzapine polymorphic form I
CA002506663A CA2506663A1 (en)	2002-12-20	2003-12-15	A process for the preparation of a pharmaceutically pure polymorphic form i of olanzapine
PCT/IB2003/005931 WO2004056833A1 (en)	2002-12-20	2003-12-15	A process for the preparation of a pharmaceutically pure polymorphic form i of olanzapine
AU2003292452A AU2003292452A1 (en)	2002-12-20	2003-12-15	A process for the preparation of a pharmaceutically pure polymorphic form i of olanzapine
CNB200380106963XA CN100354280C (zh)	2002-12-20	2003-12-15	一种制备药物纯奥氮平的多晶型ⅰ的方法
BR0317594-4A BR0317594A (pt)	2002-12-20	2003-12-15	Processo para a preparação de uma forma "i" de olanzapina polimórfica farmaceuticamente pura, produto resultante e processo para remoção da impureza "s" a partir da forma i polimórfica de olanzapina
UAA200507207A UA82213C2 (uk)	2002-12-20	2003-12-15	Спосіб очищення фармацевтично чистої поліморфної форми i оланзапіну
ES03768031T ES2294333T3 (es)	2002-12-20	2003-12-15	Procedimiento para la eliminacion de la impureza s de la forma polimorfica i de la olanzapina.
MXPA05006711A MXPA05006711A (es)	2002-12-20	2003-12-15	Un proceso para la preparacion de una forma i polimorfica farmaceuticamente pura de olanzapina.
NO20053368A NO20053368L (no)	2002-12-20	2005-07-11	Fremgangsmate for fremstilling av en farmasoytisk ren polymorf I av olanzapin.

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
PL357928A PL202856B1 (pl)	2002-12-20	2002-12-20	Sposób otrzymywania farmaceutycznie czystej polimorficznej postaci I olanzapiny

Publications (2)

Publication Number	Publication Date
PL357928A1 true PL357928A1 (pl)	2004-06-28
PL202856B1 PL202856B1 (pl)	2009-07-31

Family

ID=32678125

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL357928A PL202856B1 (pl)	2002-12-20	2002-12-20	Sposób otrzymywania farmaceutycznie czystej polimorficznej postaci I olanzapiny

Country Status (13)

Country	Link
EP (1)	EP1581537B1 (pl)
CN (1)	CN100354280C (pl)
AU (1)	AU2003292452A1 (pl)
BR (1)	BR0317594A (pl)
CA (1)	CA2506663A1 (pl)
DE (1)	DE60317712D1 (pl)
ES (1)	ES2294333T3 (pl)
HR (1)	HRP20050549A2 (pl)
MX (1)	MXPA05006711A (pl)
NO (1)	NO20053368L (pl)
PL (1)	PL202856B1 (pl)
UA (1)	UA82213C2 (pl)
WO (1)	WO2004056833A1 (pl)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU2003300324A1 (en)	2002-12-24	2004-07-22	Teva Pharmaceutical Industries Ltd.	Novel crystal forms of olanzapine, methods for their preparation and method for the preparation of known olanzapine crystal forms
WO2006025065A1 (en) *	2004-08-31	2006-03-09	Lee Pharma Private Limited	A process for the preparation of anhydrous olanzopine hydrochloride of form-1
WO2006027800A1 (en)	2004-09-06	2006-03-16	Shasun Chemicals And Drugs Limited	A novel process for preparation of a pharmaceutically pure polymorphic form 1 of olanzapine
GB0522473D0 (en)	2005-11-03	2005-12-14	Actavis Group	A pharmaceutical formulation
WO2007144901A1 (en) *	2006-06-12	2007-12-21	Jubilant Organosys Limited	Process for stabilization of olanzapine polymorphic form i
PL381564A1 (pl)	2007-01-22	2008-08-04	Koźluk Tomasz Nobilus Ent	Sposób wytwarzania zasadniczo czystej odmiany polimorficznej I olanzapiny
EP2292624A1 (en)	2009-07-20	2011-03-09	LEK Pharmaceuticals d.d.	Process for the purification of olanzapine
CN103910747B (zh) *	2014-04-24	2016-03-23	东南大学	一种奥氮平药物晶型f及其制备方法
CN109456336A (zh) *	2017-09-06	2019-03-12	万全万特制药江苏有限公司	奥氮平的精制方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5229382A (en) *	1990-04-25	1993-07-20	Lilly Industries Limited	2-methyl-thieno-benzodiazepine
GB9009229D0 (en) *	1990-04-25	1990-06-20	Lilly Industries Ltd	Pharmaceutical compounds
EG23659A (en) *	1995-03-24	2007-03-26	Lilly Co Eli	Process and crystal forms of methyl-thieno-benzodiazepine
CR5278A (es) *	1995-03-24	1996-07-04	Lilly Co Eli	Formulacion oral de 2-metil-tieno-benzodiacepina
US5631250A (en) *	1995-03-24	1997-05-20	Eli Lilly And Company	Process and solvate of 2-methyl-thieno-benzodiazepine
US6348458B1 (en) *	1999-12-28	2002-02-19	U & I Pharmaceuticals Ltd.	Polymorphic forms of olanzapine
SK2502003A3 (en) *	2000-08-31	2004-03-02	Reddys Lab Ltd Dr	Process for preparation of hydrates of olanzapine and their conversion into crystalline forms of olanzapine
PL196814B1 (pl) *	2002-05-17	2008-02-29	Inst Farmaceutyczny	Sposób wytwarzania odmiany polimorficznej I olanzapiny i jej solwaty
ATE500258T1 (de) *	2002-05-31	2011-03-15	Sandoz Ag	Verfahren zur herstellung von olanzapin form i
SI21270A (sl) *	2002-07-15	2004-02-29	Krka, Tovarna Zdravil, D.D., Novo Mesto	Kristalne oblike olanzapina in postopki za njihovo pripravo

2002
- 2002-12-20 PL PL357928A patent/PL202856B1/pl unknown
2003
- 2003-12-15 BR BR0317594-4A patent/BR0317594A/pt not_active IP Right Cessation
- 2003-12-15 CN CNB200380106963XA patent/CN100354280C/zh not_active Expired - Fee Related
- 2003-12-15 UA UAA200507207A patent/UA82213C2/uk unknown
- 2003-12-15 ES ES03768031T patent/ES2294333T3/es not_active Expired - Lifetime
- 2003-12-15 MX MXPA05006711A patent/MXPA05006711A/es unknown
- 2003-12-15 HR HR20050549A patent/HRP20050549A2/hr not_active Application Discontinuation
- 2003-12-15 EP EP03768031A patent/EP1581537B1/en not_active Expired - Lifetime
- 2003-12-15 DE DE60317712T patent/DE60317712D1/de not_active Expired - Lifetime
- 2003-12-15 WO PCT/IB2003/005931 patent/WO2004056833A1/en not_active Ceased
- 2003-12-15 AU AU2003292452A patent/AU2003292452A1/en not_active Abandoned
- 2003-12-15 CA CA002506663A patent/CA2506663A1/en not_active Abandoned
2005
- 2005-07-11 NO NO20053368A patent/NO20053368L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
WO2004056833A1 (en)	2004-07-08
MXPA05006711A (es)	2005-11-23
NO20053368D0 (no)	2005-07-11
NO20053368L (no)	2005-07-11
BR0317594A (pt)	2005-11-22
EP1581537B1 (en)	2007-11-21
AU2003292452A1 (en)	2004-07-14
PL202856B1 (pl)	2009-07-31
ES2294333T3 (es)	2008-04-01
UA82213C2 (uk)	2008-03-25
CN100354280C (zh)	2007-12-12
HRP20050549A2 (en)	2005-12-31
CA2506663A1 (en)	2004-07-08
DE60317712D1 (de)	2008-01-03
EP1581537A1 (en)	2005-10-05
CN1729195A (zh)	2006-02-01

Publication	Publication Date	Title
AU2003251247A1 (en)	2003-12-02	Methods for preparation of olanzapine polymorphic form i
PL357927A1 (en)	2003-06-30	Method of obtaining trimethylpropane
AU2003234419A8 (en)	2003-11-11	Method of forming manofluidic channels
AU2003217307A8 (en)	2003-09-02	Method for preparation of block copolymeric nanoparticles
EP1577280A4 (en)	2006-08-23	DEUTERATION PROCESS
PL360501A1 (pl)	2003-12-15	Sposób wytwarzania polimerów emulsyjnych o dużej cSposób wytwarzania polimerów emulsyjnych o dużej czystościzystości
EP1628664A4 (en)	2008-11-05	POLYMORPHIC FORMS OF NALTREXONE
PL357928A1 (pl)	2004-06-28	Sposób otrzymywania farmaceutycznie czystej polimorficznej postaci I olanzapiny
GB2385602B (en)	2004-04-21	Method of photoelectrolysis
EP1488046A4 (en)	2005-11-23	CONSTRUCTION METHODS
IL162848A0 (en)	2005-11-20	Method of obtaining citalopram
IL163977A0 (en)	2005-12-18	Improved method of making nevirapine
EP1582585A4 (en)	2006-06-07	METHOD OF SELECTING A NEW IMMUNOSUPPRESSOR
GB0217812D0 (en)	2002-09-11	Method of calibrating cantilevers
PL356465A1 (pl)	2004-04-05	Sposób wytwarzania 17beta-hydroksy-7alfa-metylo-19-nor-17alfa-pregn-5(10)-en-20-yn-3-onu
PL355037A1 (pl)	2004-01-26	Nowy sposób wytwarzania olanzapiny
AU2003299623A8 (en)	2004-08-10	Method of making mercaptoalkylalkyldialkoxysilanes
GB0220894D0 (en)	2002-10-16	Method of separation
PL351938A1 (en)	2003-08-11	Method of obtaining fructisiltransferase
GB0219671D0 (en)	2002-10-02	Method of manufacture
GB0200049D0 (en)	2002-02-20	Method of manufacture
PL357986A1 (pl)	2004-06-28	Sposób wytwarzania węglikostali
PL354072A1 (pl)	2003-12-01	Sposób wytwarzania syropuSposób wytwarzania syropu
PL356317A1 (en)	2003-04-07	Method of obtaining alkanosulphonylpyridines
PL347523A1 (en)	2001-11-05	Method of obtaining 11alpha-hydroxy-1-dehydrotestosterone